Sort
16,300 grants matching “fatty liver disease”
Defining the role of antigen-specific T cell responses in NASH
$599,541Matthew A Burchill · University Of Colorado Denver · R56 · FY2024 · DK
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
$599,356George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2022 · DK
Targeting bile acid composition to treat metabolic diseases
$599,308Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2025 · DK
Molecular Mediators and Regulators of Glucocorticoid Actions
$599,199Tomoshige Kino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$599,169Patrice Mimche · University Of Utah · R01 · FY2022 · DK
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
$599,157Robert Clayton Bauer · Columbia University Health Sciences · R01 · FY2025 · DK
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer
$599,135Andrew T Chan · Massachusetts General Hospital · R01 · FY2023 · CA
Genes and Gene Networks Associated with Obesity and Diabetes
$598,977Alan D Attie · University Of Wisconsin-Madison · R01 · FY2011 · DK
Genes and Gene Networks Associated with Obesity and Diabetes
$598,977Alan D Attie · University Of Wisconsin-Madison · R01 · FY2012 · DK
Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring
$598,883Teri L Hernandez · University Of Colorado Denver · R01 · FY2017 · DK
Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System
$598,763Mark T. Miedel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$598,736Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
The role of AEG-1 in NASH and NASH-HCC
$598,687Devanand Sarkar · Virginia Commonwealth University · R01 · FY2023 · DK
Synergy-R Diffractometer for Southeastern Wisconsin
$598,670Francis C Peterson · Medical College Of Wisconsin · S10 · FY2024 · OD
Project 1 - Dixit
$598,513Vishwa Deep Dixit · Yale University · P01 · FY2022 · AG
Advanced Non Invasive Vascular Imaging Methods
$598,480Ahmed Gharib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Metabolomic predictors of insulin resistance and diabetes
$598,445Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Mapping MTP lipid transfer activities for better therapeutics
$598,369M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2024 · HL
Novel imprint control regions (ICRs) responsive to environmental exposures
$598,076Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2023 · ES
Clinical Research Network in Non Alcoholic Steatohepati*
$597,913Kris Kowdley · University Of Washington · U01 · FY2006 · DK
Administrative Core
$597,820Janos Zempleni · University Of Nebraska Lincoln · P20 · FY2014 · GM
Role of the Macrophage in Developmentally Programmed NAFLD
$597,694Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK
Development of MR-based biomarker panels for NAFLD - A NASH CRN Ancillary Study
$597,273Claude B Sirlin · University Of California, San Diego · R56 · FY2010 · DK
CVD in American Indians Genetics Center
$597,222Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2017 · HL
CVD in American Indians Genetics Center
$597,222Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2016 · HL